Devonian Health GroupDVHGF 49 Days Inventory is 0.00 as of Apr. 2026. GuruFocus rates DVHGF with a GF Score™ of 49/100 and a GF Value™ of $2.06 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 638 Biotechnology companies, Devonian Health Group ranks better than 99.53% on this metric.
The historical rank and industry rank for Devonian Health Group's Days Inventory or its related term are showing as below:
DVHGF'
s Days Inventory Range Over the Past 10 Years
Min: 1.17 Med: 20.96 Max: 39.56
Current: 10.16
During the past 12 years, Devonian Health Group's highest Days Inventory was 39.56. The lowest was 1.17. And the median was 20.96.
DVHGF's Days Inventory is ranked better than 99.53% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs DVHGF: 10.16
Devonian Health Group's Days Inventory
declined
from Apr. 2025 (1.45) to Apr. 2026 (0.00).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Devonian Health Group's Inventory Turnover for the
three
months ended in Apr. 2026 was -1.87.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Devonian Health Group's Inventory-to-Revenue for the
three
months ended in Apr. 2026 was 0.06.
Devonian Health Group (OTCPK:DVHGF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Devonian Health Group's Inventory Turnover for the
three
months ended in Apr. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Devonian Health Group's Inventory to Revenue for the
three
months ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Devonian Health Group Days Inventory Related Terms
Devonian Health Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Devonian Health Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DVHGF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Devonian Health Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Devonian Health Group Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Devonian Health Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Devonian Health Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Devonian Health Group (DVHGF) has a Days Inventory of 0.00 as of Apr. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Devonian Health Group and its competitors. Over the past decade, Devonian Health Group's Days Inventory has ranged from 1.17 to 39.56. According to the industry distribution chart, Devonian Health Group ranks #3 out of 638 companies in the Biotechnology industry, placing it in the top 0.5%.
Is Devonian Health Group's Days Inventory too high?
Devonian Health Group's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 39.56. Based on the distribution chart, Devonian Health Group ranks #3 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Devonian Health Group has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Devonian Health Group's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Devonian Health Group ranks #3 out of 638 companies for Days Inventory. This places Devonian Health Group in the top 1% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.88. Historically, Devonian Health Group's own Days Inventory has ranged from 1.17 to 39.56 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Devonian Health Group and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Devonian Health Group's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devonian Health Group stock overvalued right now?
Based on GuruFocus' analysis, Devonian Health Group (DVHGF) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.06, compared to a current price of $7.00 — trading 239.8% above its estimated fair value. The current Days Inventory is 0.00. Devonian Health Group's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Devonian Health Group (DVHGF), the current Days Inventory is 0.00 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Devonian Health Group (DVHGF) Overvalued in 2026?
Based on GuruFocus' analysis, Devonian Health Group stock appears to be overvalued.
The current stock price of $7.00 is trading 239.8% above its estimated GF Value™ of $2.06.
GuruFocus considers Devonian Health Group to be Significantly Overvalued.
Key valuation signals for DVHGF:
Days Inventory: 0.00
GF Value™: $2.06 vs. price of $7.00 (239.8% above fair value)
No single metric tells the full story. See the DVHGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.
49GF Score
Get the complete analysis for DVHGF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DVHGF has been successfully added to your 
